National Cerebral and Cardiovascular Center

Suita 5658565

3 studies enrolling now · 9 studies all time

What they study most

Arrhythmias, Cardiac, Atherosclerotic Cardiovascular Disease (ASCVD), Atrial Fibrillation, Connective Tissue Disease-Associated Pulmonary Arterial Hypertension, Elevated Lp(a), Pediatric, Pulmonary Arterial Hypertension, Pulmonary Hypertension, Symptomatic Obstructive Hypertrophic Cardiomyopathy

Studies at this site

• Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) — Recruiting now
• Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT) — Recruiting now
• A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM). — Recruiting now
• A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) — Running, not enrolling
• Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA) — Completed
• Cryo Global Registry — Completed
• Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER — Stopped early
• Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST — Stopped early
• Reveal LINQ Registry — Completed